Community/Retail

Much research and literature has been devoted to cardiovascular diseases, neurocognitive diseases, and neuroendocrine dysfunction in the aging patient with HIV, but cancer in patients with HIV is also a growing concern.

Ajanta has launched voriconazole tablets in 50-mg and 200-mg doses in the US market. These tablets are the equivalent generic version of Vfend, an antifungal drug from Pfizer.

How often are health care professionals, especially pharmacists, asking and engaging patients to use their technology to help better manage their type 2 diabetes?

Essure received approval in 2002 and is a permanently implanted birth control device for women that is not intended to be removed.

Researchers have identified an antibody that can neutralize 98% of HIV strains, and may serve as a potential candidate for future HIV treatment and prevention.

Testimony from women at different stages of life highlights the uncertainty of women’s healthcare without the Affordable Care Act.

The holidays are just around the corner, but that’s not the only exciting thing about this time of year. ASHP’s 2016 Midyear Clinical Meeting is coming up, and Pharmacy Times is on site covering it.

Smith Drug Company has announced that Jeff Schneider, RPh has joined the company as Vice President of the company's Long Term Care Pharmacy Solutions department.

Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, talks about why it's important for children to receive their recommended immunizations.

Southeastern Grocers is donating more than 1,000 turkeys to Feeding America affiliates throughout the Southeast to help feed the one in eight people who will struggle with hunger this Thanksgiving.

Allergan has launched Taytulla, an estrogen/progestin combination oral contraceptive, in a 1-mg/20-mg capsule form.

For many years, prescribers have instructed patients to finish their entire course of antibiotics even after they start feeling better. However, recent study results have shown that longer durations of antibiotics are not always beneficial.

New research is continuously identifying the underlying mechanisms of inflammatory arthritis, which leads to better understanding of the disease and new treatments.

Flu season is under way, and, along with it, lots of confusion and unreliable information.

The American Pharmacists Association (APhA) Foundation today announced 20 recipients of its 2017 Incentive Grants for Practitioner Innovation in Pharmaceutical Care.

The FDA has approved Endoceutics' prasterone (Intrarosa), a once-daily vaginal insert for the treatment of women who experience moderate to severe pain during sexual intercourse as a result of menopause.

Human papilloma virus (HPV) causes about 31,000 cancers in women and men (and 4,000 deaths in women) annually.

Janssen has entered a clinical trial collaboration and supply agreement with Onyx to evaluate the efficacy and safety of Darzalex, the first-in-class CD38-directed immunotherapy daratumumab, in combination with a proteasome inhibitor carfilzomib and dexamethasone.

Buprenorphine is one of the most commonly prescribed medications to treat opioid addiction. In 2014, about 60-65% of Americans using medication-assisted treatment received buprenorphine. On July 6, 2016, the Department of Health and Human Services (HHS) announced that it will raise the limit on the number of patients that can receive the addiction medicine buprenorphine to 275 patients per qualified provider. This article describes potential monetary conflicts in proving buprenorphine, how increased access will affect pharmacists and what they can do to help patients in need of medication supported abstinence and substance abuse counseling.

Reports show that sales and revenue from Hepatitis C treatments are declining. What does this mean for patients?

How green is your pharmacy? Think about how much you and your coworkers are reducing, reusing, and recycling in the pharmacy.

A post-hoc analysis of a pair of phase 3 trials evaluating baricitinib in patients with rheumatoid arthritis (RA) showed significant improvement in patient-reported outcomes compared with placebo and adalimumab (Humira).

New MinuteClinic walk-in medical clinics have opened inside CVS Pharmacy stores in the Middle Village neighborhood in Queens and in Brooklyn.

Reduced reimbursements, Medicare Part D, and the Affordable Care Act have stimulated pharmacies to offer a broader palette of services.

Baptist Health and Walgreens have announced a collaboration focused on improving and coordinating healthcare to create greater convenience and value for residents of northeast Florida.

Two pharmacists are being accused for their roles in a long-running, illegal prescription pain medication distribution conspiracy.

The FDA has approved Opdivo (nivolumab) by Bristol-Myers Squibb for the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

The synthetic drug U-47700 is dangerous and is considered a major threat to public health and safety.